On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdaySep 08, 2016 8:45 am

Inventure Foods (SNAK) Boosts Kettle-Cooked Potato Chips Production through Investment in Indiana Plant

On Tuesday September 6, 2016, Inventure Foods, Inc. (NASDAQ: SNAK), a marketer and manufacturer of specialty food brands, made public an expansion of its existing kettle-cooked potato chip manufacturing capability. The company will add four new 300-pound commercial kettles and ancillary potato processing equipment to its Bluffton, Indiana, manufacturing facility. The addition of the four kettles and accessory equipment will increase the plant’s kettle cooking capacity by 50 percent and result in an additional 100,000 pounds of ‘kettle chips’ per week. The additional capacity installed by Inventure Foods was in response to increasing consumer interest in its ‘better-for-you’ line of…

Continue Reading

WednesdaySep 07, 2016 9:26 am

ArcBest Corporation (ARCB) Purchases Logistics & Distribution Services, LLC for $25 Million

ABF Logistics, an ArcBest Company (NASDAQ: ARCB), recently announced the acquisition of Logistics & Distribution Services, LLC (LDS) for $25 million. ArcBest is in the business of solving complex logistical and transportation problems. LDS is a Nevada-based private logistics and distribution company made up of around 30 employees. Founded in 2001, LDS has a second location in Pennsylvania and offers dedicated trucking operations across the U.S. In a news release announcing the acquisition, Jim Ingram, president of ABF Logistics, stated, "This acquisition complements our business nicely by adding to our existing services, specifically in deploying dedicated capacity, which will increase…

Continue Reading

WednesdaySep 07, 2016 8:52 am

Stratasys (SSYS) PolyJet 3D Printing Platform Forms Basis for Launch of Promolding’s Printed Injection Molding Division

Stratasys Ltd. (NASDAQ: SSYS), a world leader in 3D printing, announced on Friday, September 2, 2016, that Promolding, a Netherlands-based global design, engineering and manufacturing firm, will be introducing a 3D PRinted Injection Molding Division (PRIM) employing the company’s PolyJet 3D printing solutions. This approach to the production of molds is expected to reduce injection mold lead-times for Promolding customers by 93 percent. In the news release, Jeroen Gross, product development manager at Promolding, explained why his company chose Stratasys’ printing solutions: “We became increasingly aware of the need for a 3D printer that would help us optimize our product…

Continue Reading

WednesdaySep 07, 2016 8:24 am

OBI Pharma, Inc. to Present its Flagship Immunotherapy at Annual European Society for Medical Oncology Meeting

OBI Pharma, Inc., a Taiwan biotech developing therapeutic agents and next-gen active immunotherapies for a range of unmet medical needs and indications, is scheduled to host an industry-sponsored satellite symposium at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting taking place in Copenhagen, Denmark, next month. The symposium, titled "Novel Approaches to Active Immunotherapy in Oncology – Targeting Globo Series with Adagloxad Simolenin," will review data on targeting Globo Series antigens in metastatic breast cancer and other cancers with OBI Pharma’s investigational active immunotherapy, Adagloxad Simolenin (formerly OBI-822), and will examine the future of active immunotherapy in oncology.…

Continue Reading

TuesdaySep 06, 2016 11:35 am

Sully Discovery by Star Mountain Resources, Inc. (SMRS) Confirms Richness of Balmat Mine Host Rock

The announcement by Star Mountain Resources, Inc. (OTC: SMRS) of the Sully discovery validates the company’s decision to reactivate the Balmat mine. The company’s recently completed district-wide review and evaluation, which targeted zinc mineralization in the Balmat-Edwards Mining District of St. Lawrence County, New York, yielded encouraging results. The review identified significant potential zinc mineralization, labeled the ‘Sully discovery’, in the Upper Marble unit at a location approximately one mile southwest of the historic Hyatt Mine and four miles northeast of the Balmat mine. The Upper Marble unit contains the rock within which the ore deposit occurs, known as host…

Continue Reading

TuesdaySep 06, 2016 8:53 am

Moxian, Inc. (MOXC) Helping Merchants Target the Right Audiences with Intelligent Data Analytics

When it comes to social media advertising, there are a number of insights into the best way of reaching the right audience. Most experts will start by establishing a budget, choosing the right channels through which to advertise, and creating ads that they hope will kick off the process of converting viewers to customers. Smart ads are not just posted to random audiences, but rather are tailored to reach the person that fits the criteria specified for that particular ad. WordStream (http://nnw.fm/9jAUu) emphasizes that “Targeting all of your fans isn’t precise. It’s lazy and you’ll waste a lot of money.…

Continue Reading

FridaySep 02, 2016 3:59 pm

Development of CorMedix, Inc.’s (CRMD) Bloodstream Infection Therapy on Pace for Regulatory Approval

Catheter-related bloodstream infections (CRBSIs) are one of the most frequently encountered types of infections contracted in hospital units, resulting in billions of dollars in additional expenses for the U.S. healthcare system every year. It is estimated that there are roughly 250,000 CRBSIs every year, a third of them reported in ICUs. These infections lead to increased hospital stays and higher care costs ranging from approximately $4,000 to $56,000. Additionally, CRBSI cases have an attributable mortality rate of 12% to 25%. CorMedix Inc. (NYSE: CRMD), a biopharmaceutical company that focuses on developing treatments for infections and inflammatory diseases, is developing a…

Continue Reading

FridaySep 02, 2016 3:00 pm

Will ADDvantage Technologies Group, Inc. (AEY) Repeat its CATV Success in Telco?

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) has earned a reputation as a one-stop-shop in the cable TV (CATV) industry. The company, based in Broken Arrow, Oklahoma, has made a name for itself selling and servicing new, surplus and refurbished cable television equipment to CATV operators. Many of its customers are multiple system operators (MSOs) of CATV franchises and other large outfits that sell to these customers. And although mainly concentrated in the domestic market, the company has customers in Canada, Central America, South America and throughout the world. However, current trends in CATV are like the fare to be seen on…

Continue Reading

FridaySep 02, 2016 11:28 am

Nemaska Lithium, Inc. (NMKEF) Positioned to Become Lithium Hydroxide and Lithium Carbonate Supplier

According to the “Global Lithium Market Outlook” report put together by Goldman Sachs HCID Conference (http://nnw.fm/M0wCq), there are a number of trends driving lithium growth. One of the key reasons lithium has not plummeted like some commodities is the continued growth of electrical devices across the world and the high power they require from lithium-based power units. Lithium is, of course, increasingly used in a number of mobile energy systems, including EVs, producing greater energy with less weight and fewer chemicals. But lithium is also an active pharmaceutical and agro ingredient, and in other applications. According to the report, the…

Continue Reading

FridaySep 02, 2016 10:43 am

Orexigen Therapeutics, Inc. (OREX) Announces Valeant Canada will Commercialize Contrave®

Orexigen Therapeutics, Inc. (NASDAQ: OREX) recently announced a distribution agreement between its Orexigen Therapeutics Ireland Ltd. subsidiary and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) regarding the commercialization and distribution of Contrave® (naltrexone HCl / bupropion HCl extended release) in Canada. Per the agreement, Valeant Canada, a subsidiary of Valeant Pharmaceuticals, will be responsible for obtaining Canadian regulatory approval for all the commercialization activities and expenditures. Orexigen will supply Valeant Canada with Contrave tablets at an agreed price, along with potential sales and milestone payments, and expects Valeant to file for Canadian regulatory approval by January 2017. CEO of Orexigen, Mike…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217